from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0322/udgA

LFCtreatmentdescriptionclass of inhibitor

0.701

Amikacinug/mL Amikacintranslation

1.583

Cap5-10ug/mL Capreomycintranslation

2.183

Rox10-50 ug/mL Roxithromycintranslation

0.239

SM2-5 ug/mL Streptomycintranslation

1.511

Tet5-10 ug/mL Tetracyclinetranslation

0.526

Rif0.2-5ug/mL Rifampicintranscription

0.333

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.341

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.291

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.939

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.332

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.624

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.063

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.280

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.532

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.285

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.723

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.343

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.544

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.089

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.020

KCN5-20 ug/mL Potassium cyaniderespiration

-0.623

NaN30.2-2 mM Sodium aziderespiration

-0.442

Nigericin50 uM Nigericinrespiration

0.221

TRC10-150 ug/mL Triclosanrespiration

-0.449

TRZ10-25 ug/mL Thioridazinerespiration

1.184

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.524

menadione6-10 ug/mL Menadionerespiration

-0.608

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.103

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.426

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.499

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.680

NRP_1Non-replicating persistence stage 1dosRassociated

0.040

Amp0.2mg/mL AmpicillincellWall

-0.256

Cephalexin20-100 ug/mL CephalexincellWall

0.363

Cerulenin0.32-5 ug/mL CerulenincellWall

0.112

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.196

EMB10-20 ug/mL EthambutolcellWall

-0.643

Eta12-40 ug/mL EthionamidecellWall

-0.839

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.417

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.218

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.499

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.374

BZA0.12 mg/mL BenzamidearomaticAmides

0.525

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.006

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.331

H2O24 mM hydrogen peroxideDNAdamaging

-0.047

Levo10 ug/mL LevofloxacinDNAdamaging

0.750

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.109

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.202

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.679

UVUV-irradiationDNAdamaging

-0.778

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.012

Antimycin12.5-50 ug/mL Antimycin A?

-0.342

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.206

PA_110-50 ug/mL Antitubercular compound PA-1?

0.127

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.410

PA8240.2-2 ug/mL PA-824?

-1.239

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.410

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.335

Verapamil50 uM Verapamil?

-0.750

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.396

methoxatin10-20 ug/mL Methoxatin?